MB BCH BAO, University College, Dublin, Medicine
MD Equivalent, University College, Dublin, Ireland,
FRCP I, College of Physicians of Ireland
FRCPC, College of Physicians, Canada
Recent Publications:
  • Johnson KM, Safari A, Tan WC, Bourbeau J, FitzGerald JM, Sadatsafavi M on behalf of the Canadian Respiratory Research Network. Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD. Int J Chron Obstruct Pulmon Dis. 2018 Dec 13:13:3985-3995. doi: 10.2147/COPD. S184424. eCollection 2018.
  • Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, Barker P, Sproule S, Olsson RF, Martin UJ, Goldman M on behalf of the BORA study investigators. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Lancet Respir Med. 2019 Jan;7(1):46-59. doi:10.1016/S2213-2600(18)30406-5. Epub 2018 Nov 8. Erratum in: Lancet Respir Med. 2019 Jan;7(1):e1.
  • FitzGerald JM, Al Efraij K. Asthma in low-income and middle-income countries: an urgent call to action. Thorax. 2018 Oct;73(10):898-899. doi: 10.1136/thoraxjnl-2018-211718. Epub 2018 May 18.
  • Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, Goldman M, Newbold P, Zangrilli JG. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma. Eur Respir J. 2018 Oct 18;52(4). pii:1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct.
  • Buhl R, FitzGerald JM, Busse WW. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma. Respir Med. 2018 Oct;143:82-90. doi: 10.1016/j.rmed.2018.08.014. Epub 2018 Aug 29.
  • Chen W, Johnson KM, FitzGerald JM, Sadatsafavi M, Leslie WD. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study. Ach Osteoporos. 2018 Oct 29;13(1):116. doi: 10.1007/s11657-018-0537-2.

More publications can be found on PubMed.